These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 33099022)

  • 1. Artificial intelligence in drug discovery and development.
    Paul D; Sanap G; Shenoy S; Kalyane D; Kalia K; Tekade RK
    Drug Discov Today; 2021 Jan; 26(1):80-93. PubMed ID: 33099022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Artificial Intelligence Approach to Proactively Inspire Drug Discovery with Recommendations.
    Rohall SL; Auch L; Gable J; Gora J; Jansen J; Lu Y; Martin E; Pancost-Heidebrecht M; Shirley B; Stiefl N; Lindvall M
    J Med Chem; 2020 Aug; 63(16):8824-8834. PubMed ID: 32101427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence in pharmaceutical research and development.
    Mitchell JB
    Future Med Chem; 2018 Jul; 10(13):1529-1531. PubMed ID: 29966438
    [No Abstract]   [Full Text] [Related]  

  • 4. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
    Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
    Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of artificial intelligence to enhance phenotypic drug discovery.
    Malandraki-Miller S; Riley PR
    Drug Discov Today; 2021 Apr; 26(4):887-901. PubMed ID: 33484947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of AI and traditional medicine in drug discovery.
    Khan SR; Al Rijjal D; Piro A; Wheeler MB
    Drug Discov Today; 2021 Apr; 26(4):982-992. PubMed ID: 33476566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
    Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
    Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?
    Zhavoronkov A; Vanhaelen Q; Oprea TI
    Clin Pharmacol Ther; 2020 Apr; 107(4):780-785. PubMed ID: 31957003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing Drug Discovery via Artificial Intelligence.
    Chan HCS; Shan H; Dahoun T; Vogel H; Yuan S
    Trends Pharmacol Sci; 2019 Aug; 40(8):592-604. PubMed ID: 31320117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of proteomics in pharmaceutical research and development.
    Yokota H
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):17-21. PubMed ID: 29753086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence in drug development: present status and future prospects.
    Mak KK; Pichika MR
    Drug Discov Today; 2019 Mar; 24(3):773-780. PubMed ID: 30472429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Art of Virtualizing Pharma R&D.
    Schuhmacher A; Gassmann O; Kuss M; Hinder M
    Drug Discov Today; 2019 Nov; 24(11):2105-2107. PubMed ID: 31323393
    [No Abstract]   [Full Text] [Related]  

  • 14. Rethinking drug design in the artificial intelligence era.
    Schneider P; Walters WP; Plowright AT; Sieroka N; Listgarten J; Goodnow RA; Fisher J; Jansen JM; Duca JS; Rush TS; Zentgraf M; Hill JE; Krutoholow E; Kohler M; Blaney J; Funatsu K; Luebkemann C; Schneider G
    Nat Rev Drug Discov; 2020 May; 19(5):353-364. PubMed ID: 31801986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis.
    Struble TJ; Alvarez JC; Brown SP; Chytil M; Cisar J; DesJarlais RL; Engkvist O; Frank SA; Greve DR; Griffin DJ; Hou X; Johannes JW; Kreatsoulas C; Lahue B; Mathea M; Mogk G; Nicolaou CA; Palmer AD; Price DJ; Robinson RI; Salentin S; Xing L; Jaakkola T; Green WH; Barzilay R; Coley CW; Jensen KF
    J Med Chem; 2020 Aug; 63(16):8667-8682. PubMed ID: 32243158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications.
    Sumathi S; Suganya K; Swathi K; Sudha B; Poornima A; Varghese CA; Aswathy R
    Curr Pharm Des; 2023 May; 29(13):1013-1025. PubMed ID: 37055908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data.
    Bender A; Cortes-Ciriano I
    Drug Discov Today; 2021 Apr; 26(4):1040-1052. PubMed ID: 33508423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic risk identification and assessment using a new risk map in pharmaceutical R&D.
    Schuhmacher A; Brieke C; Gassmann O; Hinder M; Hartl D
    Drug Discov Today; 2021 Dec; 26(12):2786-2793. PubMed ID: 34229082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review.
    Kolluri S; Lin J; Liu R; Zhang Y; Zhang W
    AAPS J; 2022 Jan; 24(1):19. PubMed ID: 34984579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.